Trade Carefully With Soaring Gritstone Oncology
The history we are concerned about is the past couple of weeks.
UnitedHealth Group Charts Appear Toppy Ahead of Earnings
The technical indicators of the health benefits concern are not sending strong signals at present.
Moderna Now Looks Like an Effective Long Trade With Few Side Effects
MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.
Pacific Biosciences Reaches Our Price Target: Now What?
Let's check out the charts and technical indicators.
Emergent BioSolutions Is Looking Stronger
Here's an update on EBS shares.
Danaher Could Trade Higher
I do not find enough technical reasons to recommend new long positions at this point in time.
Here's Why Eli Lilly Broke to the Upside
Let's review the charts and indicators.
2 Small-Caps Still Worth Considering in This Red-Hot Market
Oncology concern Exelixis and biopharma Ardelyx offer reasons to believe their shares should rise in the months ahead.
How to Play Emergent BioSolutions Right Now
A correction in EBS could soon set up an attractive opportunity.
The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events
This Friday several banks begin the unofficial kickoff of 'earnings season'.